(1 - 18 von 23
)
Danish RNA society - 2nd Annual Meeting on RNA: from basic research...
rnasociety.dk
16:30 – 17:15 Bruce Sullenger (Duke University Medical Center, USA) "Forward and Reverse Translation with RNA aptamers and antidotes"
Scientists develop antidote for new class of drugsReuters
www.reuters.com
— Having an antidote on hand would make the treatments safer, said Bruce Sullenger of Duke University Medical Center, whose study was published in — Having an antidote on hand would make the treatments safer, said Bruce Sullenger of Duke University Medical Center, whose study was published in ...
RNA Innovation Seminar, Bruce Sullenger, Duke School of ...Happening at the University of Michigan | Happening @ Michigan
events.umich.edu
RNA Innovation Seminar, Bruce Sullenger, Duke School of Medicine. “From the RNA World to the Clinic and Back with RNA Aptamers and Enzymes”.
Designing drugs and their antidotes togetherEurekAlert!
www.eurekalert.org
— ... Bruce Sullenger, Ph.D., senior author and Vice Chair for Research and Joseph W. and Dorothy W. Beard Professor of Surgery. Yet bleeding is a — ... Bruce Sullenger, Ph.D., senior author and Vice Chair for Research and Joseph W. and Dorothy W. Beard Professor of Surgery. Yet bleeding is a ...
Improvement to CRISPR Gene Editing Could Make It More ...Duke Health
corporate.dukehealth.org
— Bruce Sullenger, Ph.D., the Joseph W. and Dorothy W. Beard Distinguished Professor of Experimental Surgery at Duke University School of Medicine — Bruce Sullenger, Ph.D., the Joseph W. and Dorothy W. Beard Distinguished Professor of Experimental Surgery at Duke University School of Medicine ...
Man-Made Antibodies Show Promise in Attacking Cancer ...Duke Health
corporate.dukehealth.org
— ... Bruce Sullenger, Ph.D., professor in the departments of Surgery and Pharmacology and Cancer Biology at Duke. “In our study, we also — ... Bruce Sullenger, Ph.D., professor in the departments of Surgery and Pharmacology and Cancer Biology at Duke. “In our study, we also ...
Man-made antibodies show promise in attacking cancer cellsDrug Target Review
www.drugtargetreview.com
— ... Bruce Sullenger, Professor in the departments of Surgery and Pharmacology and Cancer Biology at Duke. “In our study, we also developed an — ... Bruce Sullenger, Professor in the departments of Surgery and Pharmacology and Cancer Biology at Duke. “In our study, we also developed an ...
New molecule mimics the anti-clotting actionEurekAlert!
www.eurekalert.org
— ... Bruce Sullenger, Ph.D., professor in the departments of Surgery, Cell Biology, Neurosurgery and Pharmacology & Cancer Biology at Duke — ... Bruce Sullenger, Ph.D., professor in the departments of Surgery, Cell Biology, Neurosurgery and Pharmacology & Cancer Biology at Duke ...
Duke researchers develop method to make safer | EurekAlert!
www.eurekalert.org
Using blood thinners as a model, researchers at Duke University Medical Center believe they have found a way to safely turn on and off the effects of drugs, or...
Drug delivery modification sidesteps allergic responses
www.bionity.com
Meanwhile, just a few hundred yards away, a different challenge was being faced by Bruce Sullenger, the Joseph W. and Dorothy W. Beard Professor of Experimental Surgery and director of the Duke Translational Research Institute. During a late-stage clinical trial for an anticoagulant that used PEG to extend its effectiveness, 10 patients had an ...
Mit Gentherapie gegen Sichelzellanämie - Spektrum der Wissenschaft
www.spektrum.de
Einen ersten Schritt zur wirksamen Behandlung der Sichelzellanämie konnten Forscher jetzt durch Einsatz einer neuen Art von Gentherapie erzielen. Dabei…
Reversible Drug For Thromboses - HUM-MOLGEN news
hum-molgen.org
news section of the international communication forum in human genetics hum-molgen
Cleric with diverse background to lead Centralia church ...www.chronline.com › voices › cler...
www.chronline.com
Bruce Sullenger, and his wife, Tami, and sons, Sean, Benjamin and Aaron. Sullenger has been in full-time ministry since In addition to ...
Duke Researcher Targets the Message, Not the Gene, in New Approach to...
corporate.dukehealth.org
DURHAM, N.C. -- Even before the first generation of human gene therapy trials yielded spotty results, a new generation of researchers had begun rethinking how...
Man-made antibodies show promise in attacking | EurekAlert!
www.eurekalert.org
Using chemotherapy along with aptamers -- lab-made molecules that function like antibodies -- Duke Health researchers showed that they can zero in on and kill...
Modified PEG Drug Delivery Method Evades Immune System Attack
www.genengnews.com
Team reengineers PEGylated drugs to maintain their longevity and avoid allergic reactions
Technology : Renegade antibodies captured by evolving RNA | New...
www.newscientist.com
DRUGS derived from synthetic molecules of genetic material could one day combat arthritis and a range of other autoimmune diseases, according to a group of...
sortiert nach Relevanz / Datum